HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.

Abstract
A 34-year-old woman with non-Hodgkin's lymphoma received high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation (PBSCT). She developed Evans' syndrome, the association of immune thrombocytopenia and autoimmune hemolytic anemia, 49 days after transplantation. Multiple autoimmune disorders may occur concurrently after autologous PBSCT.
AuthorsK Kamezaki, T Fukuda, S Makino, M Harada
JournalClinical and laboratory haematology (Clin Lab Haematol) Vol. 26 Issue 4 Pg. 291-3 (Aug 2004) ISSN: 0141-9854 [Print] England
PMID15279667 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Anemia, Hemolytic, Autoimmune (drug therapy, etiology)
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Fatal Outcome
  • Female
  • Humans
  • Lymphoma, Non-Hodgkin (complications, therapy)
  • Peripheral Blood Stem Cell Transplantation (adverse effects)
  • Purpura, Thrombocytopenic, Idiopathic (drug therapy, etiology)
  • Recurrence
  • Remission Induction
  • Syndrome
  • Transplantation, Autologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: